SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-011248
Filing Date
2021-02-17
Accepted
2021-02-17 16:11:17
Documents
2
Period of Report
2021-02-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1669
2 POA DOCUMENT poa.txt EX-24.3_963684 3663
  Complete submission text file 0001209191-21-011248.txt   6751
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Issuer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TEVA 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Business Address
Weil Andrew (Reporting) CIK: 0001845020 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-16174 | Film No.: 21644842